CLINICAL_TRIALS
research
· 2025-09-04
Clinical Trial Update: Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer [Phase 3]
Summary
Phase 3 clinical trial comparing hypo-fractionated radiation therapy with vs without androgen suppression for intermediate-risk prostate cancer; the study is cu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Proton Collaborative Group | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING